These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20547895)

  • 1. ACP Journal Club. Use of paroxetine during tamoxifen therapy for breast cancer was associated with increased breast-cancer and all-cause mortality.
    Hillner BE
    Ann Intern Med; 2010 Jun; 152(12):JC6-13. PubMed ID: 20547895
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes.
    Melnikow J
    Ann Intern Med; 2010 Mar; 152(6):JC3-4. PubMed ID: 20231558
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Meta-analysis: adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer.
    Kiely B; Stockler M
    Ann Intern Med; 2012 Mar; 156(6):JC3-4. PubMed ID: 22431690
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Review: In women 39 to 69 years of age, screening with mammography reduces breast cancer mortality.
    Willett LR
    Ann Intern Med; 2010 Feb; 152(4):JC-27. PubMed ID: 20157131
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Individual patient meta-analysis: taxane plus anthracycline reduces mortality from early breast cancer.
    Wilcken NR; Stockler MR
    Ann Intern Med; 2012 Jun; 156(12):JC6-4. PubMed ID: 22711105
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality.
    Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-02. PubMed ID: 22508742
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Exemestane prevented invasive breast cancer in postmenopausal women at moderately increased risk.
    Willett LR
    Ann Intern Med; 2011 Oct; 155(8):JC4-3. PubMed ID: 22007062
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Risk for breast cancer declined after postmenopausal hormone therapy was stopped.
    Hillner BE
    Ann Intern Med; 2009 Jun; 150(12):JC6-11. PubMed ID: 19528556
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Estrogen plus progestin increased long-term risk for invasive breast cancer in postmenopausal women.
    Kauffman RP
    Ann Intern Med; 2011 Feb; 154(4):JC2-11. PubMed ID: 21320926
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Review: General health checks in adults do not reduce all-cause, cardiovascular, or cancer mortality.
    Lim LS
    Ann Intern Med; 2013 Jan; 158(2):JC2. PubMed ID: 23318336
    [No Abstract]   [Full Text] [Related]  

  • 11. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer.
    Fennessy M; Bates T; MacRae K; Riley D; Houghton J; Baum M
    Br J Surg; 2004 Jun; 91(6):699-704. PubMed ID: 15164437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACP Journal Club. Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer.
    Canfield SE; Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-04, JC4-05. PubMed ID: 22508744
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Radiation plus androgen deprivation therapy reduced mortality in locally advanced prostate cancer.
    Canfield SE; Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-05, JC4-04. PubMed ID: 22508745
    [No Abstract]   [Full Text] [Related]  

  • 14. Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.
    Singh MS; Francis PA; Michael M
    Breast; 2011 Apr; 20(2):111-8. PubMed ID: 21185724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.
    Bijl MJ; van Schaik RH; Lammers LA; Hofman A; Vulto AG; van Gelder T; Stricker BH; Visser LE
    Breast Cancer Res Treat; 2009 Nov; 118(1):125-30. PubMed ID: 19189212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACP Journal Club. Estrogen plus progestin increased lung cancer mortality but not incidence in postmenopausal women.
    Johnson BE; Johnson CA
    Ann Intern Med; 2010 Feb; 152(4):JC-28. PubMed ID: 20157132
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality impact of less-than-standard therapy in older breast cancer patients.
    Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
    J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACP Journal Club. Review: daily aspirin reduces short-term risk for cancer and cancer mortality.
    Diehl AK
    Ann Intern Med; 2012 Jul; 157(2):JC2-2, JC2-3. PubMed ID: 22801694
    [No Abstract]   [Full Text] [Related]  

  • 20. ACP Journal Club. Anti-tumor necrosis factor therapy was not associated with greater risk for mortality than standard therapy in rheumatoid arthritis.
    Schattner A
    Ann Intern Med; 2011 Mar; 154(6):JC3-13. PubMed ID: 21403064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.